Adipose tissue is a major source of interleukin-1 receptor antagonist: Upregulation in obesity and inflammation

Diabetes

Volumn 52, Issue 5, 2003, Pages 1104-1110

  Juge Aubry, Cristiana E ^a   Somm, Emmanuel ^a   Giusti, Vittorio ^b   Pernin, Agnès ^a   Chicheportiche, Rachel ^a   Verdumo, Chantal ^b   Rohner Jeanrenaud, Françoise ^a   Burger, Danielle ^a   Dayer, Jean Michel ^a   Meier, Christoph A ^a,c  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; CLINICAL ARTICLE; ENDOCRINE FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MOUSE; NONHUMAN; OBESITY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SPLEEN; UPREGULATION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERFERON-BETA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; ORGAN CULTURE TECHNIQUES; REFERENCE VALUES; RNA, MESSENGER; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12444290860     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.5.1104     Document Type: Article

References (30)

1. Seckinger P, Lowenthal JW, Williamson K, Dayer JM, MacDonald HW: A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol 139:1546-1549, 1987
2. Burger D, Dayer JM: IL-1Ra. In Cytokine Reference. Oppenheim JJ, Feldmann M, Eds. New York, London, Academic Press, 2000, p. 319-336
3. Arend WP, Guthridge CJ: Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis 59 (Suppl. 1):i60-i64, 2000
4. Dayer JM, Feige U, Edwards CK III, Burger D: Anti-interleukin-1 therapy in rheumatic diseases. Curr Opin Rheumatol 13:170-176, 2001
5. Dayer JM, Bresnihan B: Targeting interleukin-1 in the treatment of rheumatoid arthritis. Arthritis Rheum 46:574-578, 2002
6. Horai R, Saijo S, Tanioka M, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y: Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 191:313-320, 2000
7. Nicklin MJH, Hughes DE, Barton JL, Ure JM, Duff GW: Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 191:303-311, 2000
8. Hirsch E, Irikura VM, Paul SM, Hirsh D: Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A 93:11008-11013, 1996
9. Gabay C, Dreyer MG, Pellegrinelli N, Chicheportiche R, Meier CA: Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86:783-791, 2001
10. Jungo F, Dayer JM, Modoux C, Hyka N, Burger D: IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact. Cytokine 14:272-282, 2001
11. Vey E, Dayer JM, Burger D: Direct contact with stimulated T cells induces the expression of IL-1beta and IL-1 receptor antagonist in human monocytes: involvement of serine/threonine phosphatases in differential regulation. Cytokine 9:480-487, 1997
12. Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM: IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 87:1184-1188, 2002
13. Hauner H, Skurk T, Wabitsch M: Cultures of adipose tissue and precursor cells. In Adipose Tissue Protocols. Ailhaud G, Ed. Totowa, NJ, Humana Press, 2001, p. 197-212
14. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
15. Meier CA, Chicheportiche R, Juge-Aubry CE, Dreyer MG, Dayer JM: Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor γ. Cytokine 18:320-328, 2002
16. Mohamed-Ali V, Pinkney JH, Coppack SW: Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22:1145-1158, 1998
17. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106:473-481, 2000
18. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214, 2000
19. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
20. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803, 1996
21. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82:4196-4200, 1997
22. Kunzi MS, Rowe PP: IFNα, IFNβ, and IFNω ligands. In Cytokine Reference. Oppenheim JJ, Feldmann M, Eds. New York, London, Academic Press, 2000, p. 627-638
23. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC: Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99:861-866, 1999
24. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ: Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A 96:7047-7052, 1999
25. Beutler BA, Cerami A: Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 135:3969-3971, 1985
26. Hardardottir I, Doerrler W, Feingold KR, Grunfeld C: Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. Biochem Biophys Res Commun 186:237-243, 1992
27. Fried SK, Appel B, Zechner R: Interleukin 1α decreases the synthesis and activity of lipoprotein lipase in human adipose tissue. Horm Metab Res 25:129-130, 1993
28. Garcia-Welsh A, Schneiderman JS, Baly DL: Interleukin-1 stimulates glucose transport in rat adipose cells: evidence for receptor discrimination between IL-1 beta and IL-1 alpha. FEBS Lett 269:421-424, 1990
29. Delikat SE, Galvani DW, Zuzel M: The metabolic effects of interleukin 1 beta on human bone marrow adipocytes. Cytokine 7:338-343, 1995
30. Delikat S, Harris RJ, Galvani DW: IL-1 beta inhibits adipocyte formation in human long-term bone marrow culture. Exp Hematol 21:31-37, 1993